Resonance Health Debt 2024

Resonance Health Aktienanalyse

What does Resonance Health do?

Resonance Health Ltd is an Australian company that operates in the medical technology industry. The company's business model is to offer groundbreaking solutions for the diagnosis and treatment of liver and iron diseases. As a pioneering company in the development of methods and technologies for quantifying liver and iron concentrations, Resonance Health continually sets new standards in the industry. The company was founded in 2000 by a team of biomedicine professionals from the University of Western Australia. Over the years, the company has gained a lot of experience and constantly evolved to keep up with the progress of medical technology. The goal is to provide patients with better treatment and improved quality of life. One division of the company is the development and manufacturing of diagnostic tools for quantifying liver and iron diseases such as hepatitis, fatty liver, or hemochromatosis. The quantification method used by Resonance Health is called FerriScan. This method is non-invasive and painless, using magnetic resonance imaging (MRI) to measure the concentration of iron in the tissue. This is particularly important as a change in iron content can indicate a progressing liver disease. In addition to the FerriScan diagnostic tool, Resonance Health also offers a software package for analyzing FerriScan results, which is used by physicians and clinicians to assess disease progression. Furthermore, the company also develops solutions in the field of hemochromatosis, a genetic disorder that can lead to increased iron levels in the body. Another division of Resonance Health is the provision of research and development services to further develop and improve FerriScan and other technologies. The company collaborates with other companies, scientific institutions, and universities to advance the current developments in liver and iron diagnostics. Resonance Health has a range of products that contribute to better diagnosis and treatment of liver and iron diseases. These include FerriScan, the FerriSmart software package for precise monitoring of iron and liver health, and Hepatica, a software supporting hospitals and clinics in the diagnosis of liver diseases. The company is an innovative leader in the industry, contributing to improving the quality of life for patients. The products and services of Resonance Health have helped doctors and clinicians to effectively treat and diagnose liver and iron diseases. Additionally, the company has established a strong scientific foundation and works closely with leading institutions to continuously develop innovative solutions. Resonance Health is a company with a rich history that continues to evolve to meet the demands of the medical technology industry. The company aims to continuously improve the diagnosis and treatment of liver and iron diseases and offer better solutions. Resonance Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Resonance Health's Debt Structure

Resonance Health's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Resonance Health's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Resonance Health’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Resonance Health’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Resonance Health stock

What is the debt of Resonance Health this year?

Resonance Health has a debt level of -3.16 AUD this year.

What was the debt of Resonance Health compared to the previous year?

The debt of Resonance Health has increased by -51.52% compared to the previous year dropped.

What are the consequences of high debt for investors in Resonance Health?

High debt can pose a risk for investors of Resonance Health, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Resonance Health?

Low debt means that Resonance Health has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Resonance Health affect the company?

An increase in debt of Resonance Health can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Resonance Health affect the company?

A reduction in debt of Resonance Health can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Resonance Health?

Some factors that can influence the debt of Resonance Health include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Resonance Health so important for investors?

The debts of Resonance Health are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Resonance Health take to change the debt?

To change the debt, Resonance Health can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Resonance Health pay?

Over the past 12 months, Resonance Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Resonance Health is expected to pay a dividend of 0 AUD.

What is the dividend yield of Resonance Health?

The current dividend yield of Resonance Health is .

When does Resonance Health pay dividends?

Resonance Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Resonance Health?

Resonance Health paid dividends every year for the past 0 years.

What is the dividend of Resonance Health?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Resonance Health located?

Resonance Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Resonance Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Resonance Health from 9/17/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.

When did Resonance Health pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of Resonance Health in the year 2023?

In the year 2023, Resonance Health distributed 0 AUD as dividends.

In which currency does Resonance Health pay out the dividend?

The dividends of Resonance Health are distributed in AUD.